8722 J . Org. Chem., Vol. 64, No. 23, 1999
Notes
approximately 45 h. After the reaction had cooled to room
temperature, it was quenched by addition of H2O, and the
aqueous layer was extracted with EtOAc. The combined organic
extracts were washed with brine, dried (MgSO4), and concen-
trated in vacuo. Purification by flash column chromatography
(10:1 hexanes/EtOAc) afforded the alkylated stilbene 23 (152 mg,
42%) as a yellow oil along with some recovered starting material
(135 mg, 44%): 1H NMR δ 7.50-7.44 (m, 2H), 7.35-7.29 (m,
2H), 7.24-7.17 (m, 1H), 7.02 (d, J ) 16.3 Hz, 1H), 6.91 (d, J )
16.2 Hz, 1H), 6.90 (br s, 2H), 5.80 (s, 1H), 5.40-5.33 (tm, J )
7.2 Hz, 1H), 5.16-5.09 (tm, J ) 6.8 Hz, 1H), 3.87 (s, 3H), 3.38
(d, J ) 7.3 Hz, 2H), 2.13-2.03 (m, 2H), 2.03-1.95 (m, 2H), 1.74
(s, 3H), 1.67 (s, 3H), 1.59 (s, 3H); 13C NMR δ 146.4, 143.3, 137.6,
136.3, 131.3, 128.9, 128.9, 128.5 (2C), 127.4, 127.0, 126.1 (2C),
126.0, 124.2, 122.0, 121.1, 105.7, 55.9, 39.7, 27.9, 26.6, 25.6, 17.5,
16.1; EIMS, m/z (relative intensity) 362 (M+, 14), 279 (100), 226
(30), 137 (70), 91 (58). Anal. Calcd for C25H30O2: C, 82.82; H,
8.34. Found: C, 82.62; H, 8.37.
ter t-Bu t yld im et h ylsilyloxy-4-((E)-4-((2E)-3,7-d im et h yl-
2,6-octa d ien yl)-3,5-bis(m eth oxym eth oxy)p h en yleth en yl)-
2-m eth oxyben zen e (25). NaH (28 mg, 1.2 mmol) was added
to phosphonate 18 (257 mg, 0.53 mmol) in THF (20 mL) at 0 °C,
the ice bath was removed, and the reaction was stirred for 45
min. Aldehyde 19 (154 mg, 0.58 mmol) in THF (2.5 mL) was
then added dropwise and the reaction stirred for 10 h. The
reaction was quenched by addition of H2O and the aqueous phase
extracted with EtOAc. The combined organic phases were
washed with brine, dried (MgSO4), and concentrated in vacuo.
Purification by flash column chromatography (10:1 hexanes/
EtOAc) afforded the silylated stilbene 25 (127 mg, 40%), along
with the corresponding phenol 26 (44 mg, 17%). For stilbene
25: 1H NMR δ 7.05 (d, J ) 1.7 Hz, 1H), 7.01 (d, J ) 16.3 Hz,
1H), 6.99 (dd, J ) 8.1, 1.7 Hz, 1H), 6.96 (s, 2H), 6.93 (d, J )
16.9 Hz, 1H), 6.85 (d, J ) 8.1 Hz, 1H), 5.26 (s, 4H), 5.26 (m,
1H), 5.10 (tm, J ) 6.4 Hz, 1H), 3.89 (s, 3H), 3.53 (s, 6H), 3.43
(d, J ) 7.0 Hz, 2H), 2.10-2.03 (m, 2H), 2.03-1.95 (m, 2H), 1.82
(s, 3H), 1.67 (s, 3H), 1.60 (s, 3H), 1.04 (s, 9H), 0.20 (s, 6H); 13C
NMR δ 155.9 (2C), 151.0, 144.9, 136.6, 134.6, 131.3, 131.2, 128.2,
126.9, 124.4, 122.6, 120.9, 119.7, 119.5, 109.6, 106.0 (2C), 94.5
(2C), 55.9 (2C), 55.4, 39.8, 26.7, 25.68 (3C), 25.63, 22.7, 18.4,
17.6, 16.0, -4.7 (2C); EIMS, m/z (relative intensity) 596 (M+,
22), 595 (50), 539 (9), 46 (100).
unreacted starting material (17 mg, 40%). For compound 27:
yellow oil; H NMR (CD3OD as solvent and internal reference)
1
δ 6.98 (br s, 1H), 6.95 (d, J ) 16.2 Hz, 1H), 6.90 (s, 2H), 6.84 (d,
J ) 16.0 Hz, 1H), 6.83 (br s, 1H), 5.34-5.30 (m, 1H), 5.30-5.04
(m, 3H), 5.22 (s, 4H), 4.85 (s, 6H), 3.89 (s, 3H), 3.36 (d, J ) 7.0
Hz, 2H), 3.30 (d, J ) 7.0 Hz, 2H), 2.20-2.00 (m, 6H), 2.00-1.90
(m, 2H), 1.77 (s, 3H), 1.72 (s, 3H), 1.64 (s, 3H), 1.60 (s, 3H), 1.58
(s, 3H), 1.54 (s, 3H); 13C NMR (CD3OD as solvent and internal
reference) δ 161.9, 157.1, 148.8, 145.3, 138.3, 136.7, 135.2, 132.2,
132.1, 129.91, 129.88, 129.1, 126.8, 125.4 (2C), 124.3, 124.0,
121.9, 120.3, 107.5, 106.9 (2C), 95.7 (2C), 56.4, 56.3 (2C), 40.9
(2C), 28.9, 27.7 (2C), 26.0, 25.8, 23.4, 17.8, 17.7, 16.3, 16.2.
For the O-alkylated product 28: yellow oil; 1H NMR δ 7.02
(d, J ) 1.5 Hz, 1H), 7.01 (dd, J ) 8.6, 1.5 Hz, 1H), 6.99 (d, J )
16.3 Hz, 1H), 6.94 (d, J ) 16.0 Hz, 1H), 6.93 (s, 2H), 6.85 (d, J
) 8.3 Hz, 1H), 5.52 (tm, J ) 6.5 Hz, 1H), 5.24 (s, 4H), 5.24 (m,
1H), 5.07 (tm, J ) 6.5 Hz, 2H), 4.63 (d, J ) 6.5 Hz, 2H), 3.93 (s,
3H), 3.50 (s, 6H), 3.40 (d, J ) 7.0 Hz, 2H), 2.18-1.90 (m, 8H),
1.79 (s, 3H), 1.73 (s, 3H), 1.67 (s, 3H), 1.64 (s, 3H), 1.60 (s, 3H),
1.57 (s, 3H); 13C NMR δ 155.8 (2C), 149.5, 148.0, 140.5, 136.5,
134.5, 131.6, 131.1, 130.3, 128.0, 126.7, 124.3, 128.8, 122.6, 119.7,
119.6, 119.5, 113.0, 108.8, 105.9 (2C), 94.4 (2C), 65.8, 55.9 (2C),
55.8, 39.7, 39.5, 26.6, 26.2, 25.6 (2C), 22.6, 17.6, 17.5, 16.6, 16.0;
HR FAB-MS calcd for C39H54O6 618.3922, found 618.3902.
5-Br om o-3,4-bis(m eth oxym eth yoxy)ben za ld eh yd e (29).14
To a solution of 5-bromo-3,4-dihydroxybenzaldehyde15b (1.85 g,
8.51 mmol) in DMF (15 mL) at 0 °C was added diisopropyleth-
ylamine (3.6 mL, 38 mmol) followed by MOMCl (1.80 mL, 23.7
mmol), and the solution was stirred for 28 h while it warmed to
room temperature. The reaction was quenched by addition of
H2O and saturated NaHCO3. Ether was added, the layers were
separated, and the organic phase was washed with H2O,
saturated NaHCO3, and brine. After the organic phase was dried
(MgSO4) and concentrated in vacuo, compound 29 was obtained
as a clear oil (1.79 g, 69%). Both 1H and 13C NMR data were in
agreement with literature values.14
5-Br om o-3,4-bis(m eth oxym eth oxy)ben zyl a lcoh ol (30).
Aldehyde 29 (810 mg, 2.65 mmol) in Et2O (15 mL) was added
dropwise to a suspension of LiAlH4 (69.5 mg, 1.83 mmol) in Et2O
(60 mL) at 0 °C, and the remaining aldehyde was transferred
with additional Et2O (4 mL). After the reaction mixture was
stirred for 10 min, it was quenched by addition of EtOAc,
followed by H2O, 0.5 M NaOH, and H2O. The aqueous phase
was extracted with EtOAc, and the combined organic phases
were dried (MgSO4) and concentrated in vacuo. Purification of
the resulting oil by flash column chromatography (2:1 hexanes/
EtOAc) afforded compound 30 (619 mg, 76%) as a clear oil: 1H
NMR δ 7.20 (br s, 1H), 7.07 (br s, 1H), 5.18 (s, 2H), 5.16 (s, 2H),
4.56 (s, 2H), 3.65 (s, 3H), 3.48 (s, 3H), 2.54 (br s, 1H); 13C NMR
δ 150.8, 143.1, 138.5, 124.4, 117.7, 114.0, 98.7, 95.1, 63.9, 57.8,
56.3; EIMS, m/z (relative intensity) 308 (M++2, 14), 306 (M+,
14), 246 (5), 244 (5), 230 (100). Anal. Calcd for C11H15BrO5: C,
43.16; H, 4.94. Found: C, 42.76; H, 4.84.
[5-Br om o-3,4-b is(m e t h oxym e t h oxy)b e n zyl]t r ie t h yl-
sila n e (31). TESCl (1.60 mL, 9.41 mmol) was added to alcohol
30 (1.14 g, 3.71 mmol) in CH2Cl2 (25 mL) at 0 °C, followed by
imidazole (1.04 mg, 15.2 mmol). After the mixture was stirred
for 22 h, H2O and EtOAc were added. The aqueous phase was
extracted with EtOAc, and the combined organic layers were
washed with brine, dried (MgSO4), and concentrated in vacuo.
Purification by flash chromatography (6:1 hexanes/EtOAc) gave
compound 31 as a clear oil (1.44 g, 99%): 1H NMR δ 7.18 (d, J
) 1.2 Hz, 1H), 7.09 (d, J ) 1.3 Hz, 1H), 5.18 (s, 2H), 5.16 (s,
2H), 4.64 (s, 2H), 3.65 (s, 3H), 3.48 (s, 3H), 0.98 (t, J ) 7.9 Hz,
9H), 0.65 (q, J ) 7.9 Hz, 6H); 13C NMR δ 150.7, 142.7, 138.7,
123.6, 117.4, 113.5, 98.7, 95.1, 63.5, 57.7, 56.0, 6.6 (3C), 4.3 (3C);
EIMS, m/z (relative intensity) 422 (M+ + 2, 5), 420 (M+, 4), 215
(100), 213 (99), 117 (50). Anal. Calcd for C17H29BrO5Si: C, 48.57;
H, 6.95. Found: C, 48.40; H, 6.90.
[5-((2E)-3,7-Dim et h yl-2,6-oct a d ien yl)-3,4-b is(m et h oxy-
m eth oxy)ben zyl]tr ieth ylsila n e (32). A solution of silane 31
(177 mg, 0.42 mmol) in Et2O (10 mL) was treated with n-BuLi
(0.20 mL, 2.47 M in hexanes, 0.45 mmol) at -78 °C. After the
solution was stirred for 20 min, geranyl bromide (0.25 mL, 1.3
mmol) was added dropwise, and the reaction was allowed to
warm to room temperature and then stirred for a total of 6 h.
The reaction was quenched by addition of H2O, the aqueous
For phenol 26: 1H NMR δ 7.02 (d, J ) 1.6 Hz, 1H), 6.99 (dd,
J ) 8.1, 1.8 Hz, 1H), 6.97 (d, J ) 16.6 Hz, 1H), 6.92 (s, 2H), 6.88
(d, J ) 8.1 Hz, 1H), 6.87 (d, J ) 16.2 Hz, 1H), 5.72 (br s, 1H),
5.24 (s, 4H), 5.24 (tm, J ) 6.9 Hz, 1H), 5.07 (tm, J ) 6.9 Hz,
1H), 3.93 (s, 3H), 3.50 (s, 6H), 3.40 (d, J ) 7.4 Hz, 2H), 2.07-
2.00 (m, 2H), 2.00-1.93 (m, 2H), 1.79 (s, 3H), 1.65 (s, 3H), 1.57
(s, 3H); 13C NMR δ 155.9 (2C), 146.7, 145.5, 136.5, 134.6, 131.2,
129.9, 128.2, 126.6, 124.3, 122.6, 120.4, 119.6, 114.5, 108.1, 105.9
(2C), 94.4 (2C), 55.94 (2C), 55.85, 39.8, 26.7, 25.6, 22.7, 17.6,
16.0; EIMS, m/z (relative intensity) 482 (M+, 70), 437 (3), 359
(30), 46 (100); HR FAB-MS calcd for C29H38O6Na 505.2566, found
505.2578.
2-Met h oxy-4-((E)-4-(2(E)-3,7-d im et h yl-2,6-oct a d ien yl)-
3,5-bis(m eth oxym eth oxy)p h en yleth en yl)p h en ol (26). TBAF
(0.20 mL, 1.0 M in THF, 0.2 mmol) was added to silane 25 (119
mg, 0.20 mmol) in THF (15 mL) at 0 °C. After the solution was
stirred for 90 min, the reaction was quenched by addition of H2O
and EtOAc, and the aqueous layer was extracted with EtOAc.
The combined organic layers were dried (MgSO4) and concen-
trated in vacuo to yield compound 26 as a yellow oil (78 mg,
81%), identical with material obtained above.
6-((2E)-3,7-Dim et h yl-2,6-oct a d ien yl)-4-((E)-4-(2(E)-3,7-
d im et h yl-2,6-oct a d ien yl)-3,5-b is(m et h oxym et h oxy)p h en -
yleth en yl)-2-m eth oxyp h en ol (27). Small slices of metallic
sodium (13 mg, 0.54 mmol) were added to phenol 26 (43 mg,
0.089 mmol) in Et2O (4 mL) and the mixture stirred at room
temperaturefor 3 h. Geranyl bromide (0.04 mL, 0.20 mmol) was
then added, along with Et2O (11 mL), and the solution was
heated at reflux for 16 h. After the reaction had cooled to room
temperature, it was quenched by addition of H2O, and the
aqueous layer was extracted with EtOAc. The combined organic
layers were washed with brine, dried (MgSO4), and concentrated
in vacuo. Purification by flash column chromatography (12:1
hexanes/EtOAc) afforded the C-alkylated stilbene 27 (8 mg,
14%), along with the O-alkylated product 28 (3 mg, 6%) and